Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.66M Sell
7,340
-105
-1% -$35.9K 2.04% 16
2026
Q1
$2.6M Buy
+7,445
New +$2.65M 2.08% 15
2022
Q4
Sell
-3,600
Closed -$811K 27
2022
Q3
$811K Hold
3,600
1.22% 28
2022
Q2
$876K Sell
3,600
-400
-10% -$98K 1.27% 25
2022
Q1
$967K Hold
4,000
1.01% 27
2021
Q4
$900K Buy
+4,000
New +$844K 0.83% 31
2017
Q4
Sell
-8,000
Closed -$1.49M 57
2017
Q3
$1.49M Sell
8,000
-2,000
-20% -$354K 1.56% 20
2017
Q2
$1.72M Hold
10,000
1.73% 23
2017
Q1
$1.64M Hold
10,000
1.66% 25
2016
Q4
$1.46M Hold
10,000
1.65% 25
2016
Q3
$1.67M Buy
10,000
+2,000
+25% +$338K 1.79% 20
2016
Q2
$1.22M Buy
8,000
+500
+7% +$77.7K 1.39% 27
2016
Q1
$1.12M Buy
7,500
+1,500
+25% +$223K 1.26% 30
2015
Q4
$974K Hold
6,000
1.1% 37
2015
Q3
$830K Hold
6,000
0.95% 39
2015
Q2
$921K Buy
+6,000
New +$961K 0.93% 39

Other funds holding AMGN

P.A.W. Capital's AMGN Position: Q2 2026 in Review

P.A.W. Capital reduced its Amgen (AMGN) stake by 1.4% in Q2 2026, selling an estimated $35.9K and leaving 7,340 shares worth $2.66M. The position accounts for 2.04% of the portfolio, ranked #16.

P.A.W. Capital first reported a position in AMGN in Q2 2015 and has held it in 16 quarters since. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • P.A.W. Capital held 7,340 shares of Amgen worth $2.66M as of Q2 2026.
  • P.A.W. Capital sold 105 Amgen shares in Q2 2026, an estimated $35.9K.
  • Amgen made up 2.04% of P.A.W. Capital's portfolio in Q2 2026, its #16 holding.
  • P.A.W. Capital first reported a position in Amgen in Q2 2015 and has held it in 16 quarters since.
  • 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on P.A.W. Capital's 13F filing for Q2 2026, filed 28 Jul 2026.